- Home
- CABA vs SSTI Comparison
CABA vs SSTI Comparison
Compare CABA & SSTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABA
- SSTI
- Stock Information
- Founded
- CABA 2017
- SSTI 1996
- Country
- CABA United States
- SSTI United States
- Employees
- CABA N/A
- SSTI N/A
- Industry
- CABA Biotechnology: Biological Products (No Diagnostic Substances)
- SSTI Computer Software: Prepackaged Software
- Sector
- CABA Health Care
- SSTI Technology
- Exchange
- CABA Nasdaq
- SSTI Nasdaq
- Market Cap
- CABA 200.3M
- SSTI 160.3M
- IPO Year
- CABA 2019
- SSTI 2017
- Fundamental
- Price
- CABA $2.36
- SSTI $11.96
- Analyst Decision
- CABA Strong Buy
- SSTI Buy
- Analyst Count
- CABA 8
- SSTI 7
- Target Price
- CABA $12.75
- SSTI $20.29
- AVG Volume (30 Days)
- CABA 2.5M
- SSTI 63.6K
- Earning Date
- CABA 11-13-2025
- SSTI 11-11-2025
- Dividend Yield
- CABA N/A
- SSTI N/A
- EPS Growth
- CABA N/A
- SSTI N/A
- EPS
- CABA N/A
- SSTI N/A
- Revenue
- CABA N/A
- SSTI $103,899,000.00
- Revenue This Year
- CABA N/A
- SSTI $11.17
- Revenue Next Year
- CABA N/A
- SSTI $9.39
- P/E Ratio
- CABA N/A
- SSTI N/A
- Revenue Growth
- CABA N/A
- SSTI 1.47
- 52 Week Low
- CABA $0.99
- SSTI $9.33
- 52 Week High
- CABA $5.46
- SSTI $19.43
- Technical
- Relative Strength Index (RSI)
- CABA 61.71
- SSTI 45.50
- Support Level
- CABA $2.24
- SSTI $11.81
- Resistance Level
- CABA $2.59
- SSTI $12.25
- Average True Range (ATR)
- CABA 0.20
- SSTI 0.36
- MACD
- CABA 0.00
- SSTI -0.01
- Stochastic Oscillator
- CABA 66.28
- SSTI 39.20
About CABA Cabaletta Bio Inc.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.
About SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.